X4 Pharmaceuticals (XFOR) Enterprise Value (2018 - 2025)
Historic Enterprise Value for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to -$69.6 million.
- X4 Pharmaceuticals' Enterprise Value rose 2851.8% to -$69.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$69.6 million, marking a year-over-year increase of 2851.8%. This contributed to the annual value of -$55.7 million for FY2024, which is 4386.09% up from last year.
- As of Q3 2025, X4 Pharmaceuticals' Enterprise Value stood at -$69.6 million, which was up 2851.8% from -$39.2 million recorded in Q2 2025.
- X4 Pharmaceuticals' Enterprise Value's 5-year high stood at -$39.2 million during Q2 2025, with a 5-year trough of -$147.2 million in Q2 2024.
- In the last 5 years, X4 Pharmaceuticals' Enterprise Value had a median value of -$81.8 million in 2021 and averaged -$87.1 million.
- In the last 5 years, X4 Pharmaceuticals' Enterprise Value plummeted by 18782.28% in 2023 and then surged by 7335.92% in 2025.
- Over the past 5 years, X4 Pharmaceuticals' Enterprise Value (Quarter) stood at -$81.8 million in 2021, then crashed by 48.82% to -$121.7 million in 2022, then rose by 18.49% to -$99.2 million in 2023, then surged by 43.86% to -$55.7 million in 2024, then fell by 25.01% to -$69.6 million in 2025.
- Its Enterprise Value stands at -$69.6 million for Q3 2025, versus -$39.2 million for Q2 2025 and -$40.3 million for Q1 2025.